News & Updates
Filter by Specialty:
Long COVID may persist for months, resolve within a year
Patients with mild COVID-19 may encounter a few health concerns for several months following SARS-CoV-2 infection, but these outcomes tend to resolve within a year from diagnosis, reveals a study.
Long COVID may persist for months, resolve within a year
30 Jan 2023
SAVE-MORE subgroup analysis further reinforces anakinra benefit in COVID-19
The benefit of anakinra treatment in patients hospitalized with COVID-19 is consistent regardless of age, sex, comorbidities, and suPAR* levels, according to subgroup analysis of the SAVE-MORE trial.
SAVE-MORE subgroup analysis further reinforces anakinra benefit in COVID-19
27 Jan 2023
Rehabilitation plus robotic therapy improves outcomes in COVID-19 patients
Inpatient rehabilitation with a comprehensive rehabilitation program offers benefits to post-COVID-19 patients, reports a Singapore study, noting that functional outcomes may be further improved with adjunct robotic therapy.
Rehabilitation plus robotic therapy improves outcomes in COVID-19 patients
25 Jan 2023
Fluvoxamine strikes out in mild-to-moderate COVID-19
Treatment with fluvoxamine does not appear to improve outcomes in patients with mild-to-moderate COVID-19, with a study showing that the drug does not shorten symptom duration as compared with placebo.
